Journal of Vaccines and Immunology Submit Manuscript

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesYes
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editorial Board

    Salvatore Pellegrino
    Paediatric Gastroenterology and Cystic Fibrosis
    University of Messina
    Italy
    JVI

    Research Interest: Inflammatory bowel diseases coeliac disease, Cystic fibrosis.

    More Info.
    Ting Wang
    Professor, School of Pharmacy
    Anhui Medical University
    China
    JVI

    Research Interest: Nanoparticles, liposomes, solid lipid naonparticles, and anhydrous reverse micelles, drug/vaccine carriers, freeze-drying of pharmaceutics, design, carrying out and analysis of in vivo tests, separation and purification of chemicals, extraction and analysis of therapeutic.

    More Info.
    Manmohan Singh
    Head
    Global Drug Product Development
    Technical Development Novartis Vaccines
    USA
    JVI

    Research Interest: He focused on developing novel adjuvants and vaccine delivery systems for prophylactic vaccination along with rational design of new vaccine formulations for Novartis discovery projects.

    More Info.
    Jing Wang
    Associate Professor
    Institute of Oceanology
    China
    JVI

    Research Interest: The structure of sulfated polysaccharides extracts from seaweeds. The activity of sulfated polysaccharides such as nephrophaty and Parkinsion Disease. The comprehensive utilization of seaweeds especially Saccharina japonica.

    More Info.
    Silvia Della Bella
    Associate Professor in General Pathology and Immunology
    University of Milan
    Italy
    JVI

    Research Interest: Immunology, chronic viral infections (hepatitis C virus, Kaposi's sarcoma herps virus), dendritic cells, B cells.

    More Info.
    Suh-Chin Wu
    Professor
    Institute of Biotechnology
    National Tsing Hua University
    Taiwan
    JVI

    Research Interest: Biotechnology, Vaccines, Vaccine Development, Virology, Viral Vaccines.

    More Info.
    Chiara Cadeddu
    Institute of Public Health
    Catholic University of Sacred Heart
    Italy
    JVI

    Research Interest: Public Health and Health Technology Assessment, particularly for vaccines. 

    More Info.
    Mishra Kamla Prasad
    Department of Allied Sciences
    Defence Institute of Physiology
    India
    JVI

    Research Interest: Develop treatment modality/Process/Biomarkers for the soldiers working in the extreme conditions. Based on these stressors, different models of stress like hypobaric hypoxia, cold, Isolation (Antarctica) and viral infection are being used to overcome from the stress induced maladies.

    More Info.
    Rajagopal Appavu
    Department of Experimental Radiation Oncology
    University of Texas MD Anderson Cancer Center
    USA
    JVI

    Research Interest: Structural determination of protein-DNA, Solid: X-ray, Solution: 2D & 3D NMR, and Gas: Mass Spectrometry, interactions and their pathways, stability, dynamics, and function.

    More Info.
    Han Zhang
    Emory University
    USA
    JVI
    More Info.
    Bing Ni
    Professor
    Institute of Immunology
    PLA Third Military Medical University
    China
    JVI

    Research Interest: Epigenetic regulation of virus or autoimmune diseases on host immune cells such as Treg, Th17 and innate lymphoid cells (ILCs).

    More Info.
    Merghoub Taha
    Associate Biologist
    Memorial Sloan Kettering Cancer Center
    USA
    JVI

    Research Interest: Pathogenesis and Treatment of Melanoma, and in Part are directed at Developing Tools to Study Melanoma.

    More Info.
    Bingyun Li
    Professor
    Department of Orthopaedics
    West Virginia University
    USA
    JVI

    Research Interest: Nanomedicine, Controlled/Targeted Drug Delivery, Toxicology, Pharmacology, Cellular Interaction, Nanofilms and Microcapsules, Biomimetic, Microbiology, Immunology.

    More Info.
    Yadong Zheng
    Lanzhou Veterinary Research Institute
    Chinese Academy of Agricultural Sciences
    China
    JVI

    Research Interest: Vaccine, innate immunity, parasite-host interaction.

    More Info.
    Krzysztof Jerzy Rypula
    Division of Infectious Diseases and Veterinary Administration
    Wroclaw University
    Poland
    JVI

    Research Interest: Infectious diseases in animals, diagnostics, epidemiology, efficiency of vaccination programmes.

    More Info.
    View more
    mendeley

    Lessons from COVID-19: Overcoming Vaccine Hesitancy for the Malaria Vaccine in Africa

    DOI Logo 10.17352/jvi.000061

    Published On: June 13, 2025 | Pages: 001 - 003

    Author(s): Audry Marorerwa*, Guy Tresor Karikera and Egide Haragirimana
    Abstract View Full Article View
    mendeley

    Post-vaccinal reactions following vaccination with the COVID-19 vaccine after first and second dose

    DOI Logo 10.17352/jvi.000060

    Published On: March 05, 2024 | Pages: 006 - 010

    Author(s): Velina Stoeva*, Rosen Mihaylov, Blagovesta Pencheva and Antoineta Mihova

    ORCID Logo  0000-0002-6239-4418

    Abstract View Full Article View
    mendeley

    Considerations for improving future pandemic responses

    DOI Logo 10.17352/jvi.000059

    Published On: February 08, 2024 | Pages: 001 - 005

    Author(s): Mikolaj Raszek*, David Cowley and Alberto Rubio-Casillas

    ORCID Logo  0009-0003-5755-3415

    Abstract View Full Article View
    mendeley

    Evaluation of Anti-SARS-CoV-2 IgG antibody response following COVISHEILD vaccination: A comparison between previously infected and non-infected cohorts

    DOI Logo 10.17352/jvi.000058

    Published On: August 19, 2023 | Pages: 030 - 036

    Author(s): Md Shakeel Ahmed*, Md Zakir Hossain, Md Mamunur Rashid, Istiak Ahmad, Md Zahirul Islam, Meherab Hossain and Hasan Rabbi

    ORCID Logo  0000-0002-3405-2146

    Abstract View Full Article View
    mendeley

    Dietary intervention in enhancing immunity of cancer patients

    DOI Logo 10.17352/jvi.000057

    Published On: August 09, 2023 | Pages: 024 - 029

    Author(s): Dietary intervention in enhancing immunity of cancer patients

    ORCID Logo  0000-0001-8856-3681

    Abstract View Full Article View
    mendeley

    Percutaneous Patent Ductus Arteriosus (PDA) closure: When and how to close Coil VS Occluder “step by step” cases report

    DOI Logo 10.17352/jvi.000056

    Published On: March 22, 2023 | Pages: 015 - 023

    Author(s): Nassime Zaoui*, Amina Boukabous, Nabil Irid, Katia Babou and Sabrina Benamara
    Abstract View Full Article View
    mendeley

    Study of adverse events following 2018 sub-national yellow fever vaccination in Ghana

    DOI Logo 10.17352/jvi.000055

    Published On: February 25, 2023 | Pages: 006 - 014

    Author(s): Douglas Adu-Fokuo, Feng Cheng*, Emily Yin and Elizabeth Giwa
    Abstract View Full Article View
    mendeley

    Alopecia areata

    DOI Logo 10.17352/jvi.000054

    Published On: February 21, 2023 | Pages: 001 - 005

    Author(s): Chieh Chen*

    ORCID Logo  0000-0001-5784-9855

    Abstract View Full Article View
    mendeley

    Characterization of enterotoxigenic Escherichia coli heat-labile toxin (LT) double mutant LTA72R/R192G as a Nontoxic and Effective Mucosal Adjuvant

    DOI Logo 10.17352/jvi.000053

    Published On: October 26, 2022 | Pages: 033 - 039

    Author(s): Li Ben-Qiang, Tao Jie, Cheng Jing-Hua, Shi Ying and Liu Hui-li*
    Abstract View Full Article View
    mendeley

    Effect of a third booster dose of COVID-19 mRNA vaccine in patients with haematological cancer after the initial two-dose vaccination - a single centre report

    DOI Logo 10.17352/jvi.000052

    Published On: August 08, 2022 | Pages: 029 - 032

    Author(s): Šušol Ondrej, Šušolová Barbora and Hájek Roman*
    Abstract View Full Article View

     

    Indexing/Archiving